Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
https://www.zacks.com/stock/news/2259368/is-a-beat-likely-for-west-pharmaceutical-wst-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259368
Apr 22, 2024 - West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
0
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
https://www.zacks.com/stock/news/2258737/will-acute-care-unit-aid-universal-health-s-uhs-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258737
Apr 19, 2024 - Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.
0
Will Humana (HUM) Q1 Earnings Beat on CenterWell Strength?
https://www.zacks.com/stock/news/2258552/will-humana-hum-q1-earnings-beat-on-centerwell-strength?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258552
Apr 19, 2024 - Humana's (HUM) first-quarter results are likely to reflect rising premiums and investment income.
0
Will Low Patient Days Impact Community Health (CYH) Q1 Earnings?
https://www.zacks.com/stock/news/2257857/will-low-patient-days-impact-community-health-cyh-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257857
Apr 18, 2024 - Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.
0
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
https://www.zacks.com/stock/news/2257849/bio-rad-laboratories-bio-to-post-q1-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257849
Apr 18, 2024 - The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
0
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://www.zacks.com/stock/news/2257726/edwards-lifesciences-ew-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2257726
Apr 18, 2024 - Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?
https://www.zacks.com/stock/news/2257013/is-a-beat-likely-for-edwards-lifesciences-ew-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257013
Apr 17, 2024 - The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.
0
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
https://www.zacks.com/stock/news/2256354/is-a-beat-likely-for-intuitive-surgical-isrg-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256354
Apr 16, 2024 - Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
0
UnitedHealth Group (UNH) Tops on Q1 Earnings, Reaffirms EPS View
https://www.zacks.com/stock/news/2256331/unitedhealth-group-unh-tops-on-q1-earnings-reaffirms-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2256331
Apr 16, 2024 - UnitedHealth Group (UNH) first-quarter earnings benefit from strong Optum and UnitedHealthcare business lines. Rising expenses partially offset the positives.
0
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2256315/align-technology-algn-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256315
Apr 16, 2024 - Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.
0
Page 1>